Skip to the content

KD&A - Regulatory Consultants for Medical and IVD devices

kdent@kdas.com.au
logo mainlogo darklogo light
  • About Us
    • About Us
    • What our Clients Say
    • Frequently Asked Questions
  • Our Services
    • Medical Device Regulatory Strategy
    • ISO 13485/ MDSAP QMS Maintenance, Internal Audit and Support
    • Technical File Documentation
    • Global Medical Device Registrations including ARTG Inclusions/TGA Registrations
    • Post Market Surveillance
    • TGA Conformity Assessment / CE Marking
    • Promotional Materials Review
    • Australian TGA Sponsor Services
    • Medical Device and IVD Classification Assessment
    • Software as a Medical Device (SaMD)
  • Our Clients
    • Australian Sponsors & Distributors
    • Medical Device Manufacturers
    • International Medical Device Manufacturers
    • Our Clients
  • News
  • Useful Links
Get In Touch
logo main
  • About Us
    • What our Clients Say
    • Frequently Asked Questions
    • Useful Links
  • Our Services
    • Medical Device Regulatory Strategy
    • ISO 13485/ MDSAP QMS Maintenance, Internal Audit and Support
    • Technical File Documentation
    • Global Medical Device Registrations including ARTG Inclusions/TGA Registrations
    • Post Market Surveillance
    • TGA Conformity Assessment / CE Marking
    • Promotional Materials Review
    • Australian TGA Sponsor Services
    • Medical Device and IVD Classification Assessment
    • Software as a Medical Device (SaMD)
  • Our Clients
    • Australian Sponsors & Distributors
    • Medical Device Manufacturers
    • International Medical Device Manufacturers
  • Latest News
  • Contact Us

GHTF Tag

20
Sep
Regulatory ChangesTGA

GHTF Release New Standard

In light of the recent PIP breast implant adverse events and other significant device recalls, the GHTF has finalised a new standard called N87 (based on a previous guidance docum

Read More
Share
02
Mar
Regulatory Changes

Brazil IVD Requirements – Aligned with GHTF Principles

Brazil’s regulatory agency, Anvisa, has introduced reforms to simplify classification processes for IVD products. From the 18th of May 2012 IVD manufacturers will be subject to

Read More
Share
23
Feb
Regulatory Changes

In-house IVDs – TGA Release New Guidance

The TGA have published a guidance document for manufacturers of in-house IVDs (in-vitro diagnostic device) to assist in ensuring compliance with the new regulatory framework, relea

Read More
Share
16
Feb
Regulatory Changes

What Does Recall Really Mean? The GHTF Aim to Provide Clarity

The recent PIP breast implant saga is a reminder of just how important it is for us, the medical device industry, to have a universal system for identifying, classifying and resolv

Read More
Share
News Categories
  • EU
  • FDA
  • Regulatory Changes
  • Research
  • Software
  • Technology
  • TGA
  • Uncategorized
Latest Articles
March 20, 2025
Understanding Requirements for Medical Devices Containing Medicinal, Microbial, Recombinant, or Animal Origin Substances
February 13, 2025
TGA Recall Reforms: A Closer Look at the PRAC
December 6, 2024
KD&A Can Help You From the Start – Medical Devices Steps to Market
Tags

Australia Australian Medical Device Regulatory Framework European Union Manufacturer's Evidence Medical Device Medical Device Regulations Medicinal Substances Regulatory Changes Regulatory Compliance Regulatory Requirements Regulatory Strategy TGA

  • What We Do
  • Who We Help
  • What our Clients Say
+ 61 411 101 392
kdent@kdas.com.au

Get our latest expert updates to your inbox

KD&A provides expert regulatory consulting service to medical device and IVD companies selling on Australian and International markets.

    Contact us:
    kdent@kdas.com.au
    +61 411 101 392
    Our address:
    Level 3, Suite 301,
    27 Belgrave Street,
    Manly NSW, Australia
    Our social:
    Terms and conditions
    Privacy policy
    © 2025 KD&A Pty Ltd
    w

    Lorem ipsum dolor sit amet, consectetur adipiscing elit eiusmod tempor

    w
    leroux@qodeinteractive.com